(Q35865773)

10 August 2017

1 reference

title

Pathology and molecular genetics of astrocytic gliomas (English)

1 reference

10 August 2017

1 reference

1

Guido Reifenberger

1 reference

10 August 2017

Vincent Peter Collins

series ordinal

2

1 reference

10 August 2017

1 October 2004

1 reference

Journal of Molecular Medicine

10 August 2017

1 reference

10 August 2017

82

1 reference

10 August 2017

656-670

1 reference

10 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-004-0564-x

10 August 2017

0 references

cites work

Glioblastomas with an oligodendroglial component: a pathological and molecular study.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Pleomorphic xanthoastrocytoma: what do we really know about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Promoter hypermethylation of the RB1 gene in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Loss of heterozygosity on chromosome 19 in secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Genetic profile of gliosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-004-0564-X

Using mice to decipher the molecular genetics of brain tumors

21 January 2018

1 reference

12 December 2020

Immunophenotype of pleomorphic xanthoastrocytoma.

1 reference

12 December 2020

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme

1 reference

12 December 2020

The history of cancer epigenetics

1 reference

12 December 2020

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

1 reference

12 December 2020

Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes

1 reference

12 December 2020

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

1 reference

12 December 2020

Mouse models of human cancer consortium symposium on nervous system tumors

1 reference

12 December 2020

Temozolomide for recurrent high-grade glioma

1 reference

12 December 2020

Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.

1 reference

12 December 2020

Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.

1 reference

12 December 2020

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

1 reference

12 December 2020

Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

1 reference

12 December 2020

Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2

1 reference

12 December 2020

Mouse glioma gene expression profiling identifies novel human glioma-associated genes

1 reference

12 December 2020

1 reference

12 December 2020

Long-term glioblastoma multiforme survivors: a population-based study.

1 reference

12 December 2020

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

1 reference

12 December 2020

p53 and PTEN gene mutations in gemistocytic astrocytomas.

1 reference

12 December 2020

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

1 reference

12 December 2020

Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme.

1 reference

12 December 2020

Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas

1 reference

12 December 2020

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

1 reference

12 December 2020

MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials

1 reference

12 December 2020

A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Molecular genetic analysis of giant cell glioblastomas

1 reference

12 December 2020

Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma.

1 reference

12 December 2020

Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival

1 reference

12 December 2020

Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.

1 reference

12 December 2020

Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components

1 reference

12 December 2020

Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

1 reference

12 December 2020

High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.

1 reference

12 December 2020

Promoter hypermethylation of multiple genes in astrocytic gliomas.

1 reference

12 December 2020

Oncogenic Ras and Akt Signaling Contribute to Glioblastoma Formation by Differential Recruitment of Existing mRNAs to Polysomes

1 reference

12 December 2020

Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas.

1 reference

12 December 2020

Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome

1 reference

12 December 2020

Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group stud

1 reference

12 December 2020

DNA methylation in brain development and gliomagenesis

1 reference

12 December 2020

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

1 reference

12 December 2020

Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors

1 reference

12 December 2020

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

1 reference

12 December 2020

Trends in incidence of primary brain tumors in the United States, 1985-1994.

1 reference

12 December 2020

Genetic modeling of glioma formation in mice.

1 reference

12 December 2020

Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.

1 reference

12 December 2020

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

1 reference

12 December 2020

p14ARF deletion and methylation in genetic pathways to glioblastomas.

1 reference

12 December 2020

Increasing incidence of primary malignant brain tumors: influence of diagnostic methods

1 reference

12 December 2020

Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.

1 reference

12 December 2020

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

1 reference

12 December 2020

Epidermal growth factor receptor and Ink4a/Arf

1 reference

12 December 2020

Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosisA study of 12 cases

1 reference

12 December 2020

Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival

1 reference

12 December 2020

High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors.

1 reference

12 December 2020

Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma

1 reference

12 December 2020

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

12 December 2020

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

12 December 2020

Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.

1 reference

12 December 2020

Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma.

1 reference

12 December 2020

Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis

1 reference

12 December 2020

Analysis of pilocytic astrocytoma by comparative genomic hybridization.

1 reference

12 December 2020

Genetic profile of the giant cell glioblastoma.

1 reference

12 December 2020

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994

1 reference

12 December 2020

The INK4 family of cell cycle inhibitors in cancer

1 reference

12 December 2020

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

12 December 2020

MGMT: its role in cancer aetiology and cancer therapeutics

1 reference

12 December 2020

Molecular genetic alterations in glioblastomas with oligodendroglial component.

1 reference

12 December 2020

Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas

1 reference

12 December 2020

Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas

1 reference

12 December 2020

Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.

1 reference

12 December 2020

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

12 December 2020

The p16INK4a/CDKN2A tumor suppressor and its relatives.

1 reference

12 December 2020

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

12 December 2020

Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.

1 reference

12 December 2020

Increasing annual incidence of primary malignant brain tumors in the elderly.

1 reference

12 December 2020

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

1 reference

12 December 2020

Primary and secondary glioblastomas: from concept to clinical diagnosis

1 reference

12 December 2020

Short postoperative survival for glioblastoma patients with a dysfunctional Rb1 pathway in combination with no wild-type PTEN.

1 reference

12 December 2020

Gliomagenesis: genetic alterations and mouse models

1 reference

12 December 2020

Genetically engineered mouse models of astrocytoma: GEMs in the rough?

1 reference

12 December 2020

Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops

1 reference

12 December 2020

Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum

1 reference

12 December 2020

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

1 reference

12 December 2020

Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization.

1 reference

12 December 2020

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

1 reference

12 December 2020

RETRACTED: Pretreatment with oral clonidine attenuates cardiovascular responses to tracheal extubation in children.

1 reference

11 February 2024

https://opencitations.net/index/api/v1/citations/10.1046/J.1460-9592.2000.00441.X

Identifiers

DOI

10.1007/S00109-004-0564-X

1 reference

10 August 2017

1 reference

PubMed ID

15316624